A trial comparing standard treatment versus a new combination of treatments for locally advanced rectal cancer

Update Il y a 4 ans
Reference: EUCTR2008-005782-59

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Some patients with rectal cancer benefit from receiving chemotherapy and radiotherapy before they have an operation to remove their tumour. This trial will determine whether the addition of a second drug (irinotecan) to the standard treatment of oral chemotherapy using capecitabine and radiotherapy will result in fewer cancer recurrences (regrowth) after the operation and if patients live longer.


Inclusion criteria

  • Locally advanced rectal cancer